Pharmacy numbers dropped from 11,522 in 2022 to 11,414 in 2023, and a further 436 closed this year in 2024. As numbers ...

Join us for live coverage of JP Morgan Healthcare Conference, where life sciences leaders congregate in San Francisco to network and make deals. Join the conversation, on Tuesday 28th January @ 10 am ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

"Clinical evidence suggests that the AI technologies may improve fracture detection on X‑rays in urgent care without ...

Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in ...

Over more than eight years of monitoring, getting familiar with the EU CTR, conducting trial submissions activities, etc., ...

And yet, data science is now poised to usher in a level and acceleration of progress that even life sciences have never ...

But for an industry in which 46 recalls is 46 too many, given the potentially immense costs these incidents can exact, the ...

The two companies, along with 17 US health systems, will collectively take a $320 million stake in Truveta, with Regeneron ...